Answers are grounded in this paper and cite their sources.
Fine particulate matter (PM2.5) pollution’s harmful effects on the environment and human health have gained global attention. After entering the liver via the bloodstream, these small particles could disrupt hepatic lipid metabolism and even cause liver damage, but the underlying mechanisms remain unclear. To investigate the impact of PM2.5 on the liver and metabolism, ApoE−/− mice were used and then exposed to PM2.5 to establish a hyperlipidemic model. Our findings revealed the involvement of oxidative stress in this model, which was accompanied by elevated expression of inflammatory markers and enhanced GSDMD-mediated pyroptosis activation. Our results further show that PM2.5 exposure causes significant alterations in key metabolic hepatic proteins. Inhibiting pyroptosis with disulfiram (DSF) balances hepatic lipid-protein levels and decreases hepatic injury, suggesting its potential to protect the liver from PM2.5 exposure. N-acetyl-L-cysteine (NAC) treatment reversed PM2.5-induced oxidative stress, inhibiting pyroptosis and improving hepatocyte function, as demonstrated by the restored balance of hepatic proteins. Our investigation establishes a critical link between PM2.5 exposure and liver dysfunction through oxidative stress and pyroptosis pathways while demonstrating the therapeutic potential of DSF and NAC in protecting against PM2.5-induced metabolic disorders and hepatic injury. These insights provide a foundation for developing targeted interventions to address air pollution-related liver diseases, especially in vulnerable high-lipid populations.
No takes yet. Share an insight, caveat, or question.
Tahir et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: